To clarify the clinical significance of IDO1 and Pyk2 phosphorylation in the progression of breast cancer, we examined the protein expression of IDO1 and Pyk2 phosphorylation in the tumor tissues of 136 patients with breast cancer. This evidence concerns the gene PTK2B and breast carcinoma.